Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
European Journal of Clinical Nutrition
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
March 1997, Volume 51, Number 3, Pages 181-187
Table of contents    Previous  Abstract  Next   Article  PDF
Original communication
Use of oral contraceptives and serum beta-carotene
G Berg1, L Kohlmeier2 and H Brenner1

1Department of Epidemiology, University of Ulm, Albert-Einstein-Allee 43, 89069 Ulm, Germany

2Department of Nutrition, University of North Carolina, Chapel Hill, NC 27514, USA

Correspondence: G Berg.

Abstract

Objective: Antioxidants, in particular carotenoids, may influence the risk for cardiovascular disease. This study investigates the influence of oral contraceptives (OC) on the serum concentration of beta-carotene, which may in turn affect the risk of cardiovascular diseases due to its antioxidative impact.

Design: Cross-sectional epidemiologic study. Examinations included a detailed questionnaire on medical history and lifestyle factors, a 7 day food record, and blood samples.

Setting: National health and nutrition survey among healthy people living in private homes in West Germany in 1987-1988.

Subjects: Nonpregnant and nonlactating women aged 18-44 (n=610).

Results: Overall, the use of OC was negatively associated with serum beta-carotene concentration in bi- and multivariable analyses after adjustment for age, smoking, alcohol consumption, dietary intake of beta-carotene, use of vitamin supplements, body mass index, pregnancies, and serum concentrations of total triglyceride and cholesterol. A strong interaction between OC use and age on beta-carotene concentration was observed. While no relationship between OC use and serum beta-carotene was seen in the youngest age-group (18-24 y), there was a modest but significant negative association between OC use and beta-carotene levels among 25-34 y old women. The use of OC was associated with a strong decrease in beta-carotene levels among 35-44 y old women. The interaction between OC use and age could partly be explained by age dependent use of OC with higher estrogen content.

Conclusions: OC use seems to be strongly related to serum beta-carotene levels, particularly among women above the age of 35. Further studies are needed to clarify the underlying mechanisms of this association and its implications for health risks of OC use.

Sponsorship: The national health and nutrition survey was founded by the German Ministry of Research and Technology.

Keywords

oral contraceptive; beta-carotene; cardiovascular disease

Received 21 August 1996; revised 18 November 1996; accepted 22 November 1996
March 1997, Volume 51, Number 3, Pages 181-187
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1997 Nature Publishing Group